Time For Treks to Host San Diego Cancer Walk

The campaign will host a community walk at Cabrillo National Monument to encourage outdoor movement for those living with CLL.

Updated on Oct. 14, 2026 in Cancer

Gouache-painted illustration of a rustic wooden trail marker on a coastal cliff, evoking the restorative nature of outdoor movement.
The Time For Treks campaign launches in San Diego on October 17, offering a new community-based wellness initiative for patients with CLL. AI Illustration. Upload story photo >

Live Poll

Do you trust pharmaceutical-sponsored lifestyle programs to prioritize patient well-being over corporate interests?

On October 17, 2026, the Time For Treks campaign will launch in San Diego with a community walk at Cabrillo National Monument. This initiative invites people with chronic lymphocytic leukemia (CLL) to engage in outdoor activities as part of a new community-focused wellness program.

Why it matters

The campaign aims to support the emotional and physical well-being of the CLL community by fostering connection and active outdoor experiences. It was developed in response to patient feedback identifying hiking as a preferred way to stay active after a diagnosis.

AbbVie conducted a 2024 survey regarding the emotional experience of a CLL diagnosis to inform the campaign. While this effort centers on lifestyle, the clinical long-term effectiveness of outdoor engagement on cancer outcomes remains an area of ongoing interest.

The players

AbbVie

A global biopharmaceutical company known for developing oncology therapies, including treatments for blood cancers.

CLL Society

A patient-centric organization providing education and support services for those living with chronic lymphocytic leukemia.

National Park Foundation

The official nonprofit partner of the National Park Service dedicated to preserving protected lands.

The details

Co-created with patients, the Time For Treks campaign leverages educational resources to encourage movement for individuals managing CLL. Participants utilize physical activity to foster community connections, a practice that builds on the company's broader involvement in oncology since the 2013 approval of Imbruvica and the 2016 launch of Venclexta.

Timeline

  1. 2013: Imbruvica received initial regulatory approval.

  2. 2016: Venclexta first hit the market.

  3. 2024: AbbVie conducted a survey on CLL diagnosis impacts.

  4. 2025: AbbVie released the Second Winds short film.

  5. October 17, 2026: Campaign launch and community walk at Cabrillo National Monument.

Health Landscape

This program reflects a broader shift in oncology support toward holistic, lifestyle-based initiatives that complement traditional medical care. It builds on the infrastructure of the AbbVie oncology education and support framework to provide non-clinical resources for cancer survivors.

If you are managing a CLL diagnosis, engaging in gentle outdoor activities like walking can be a positive way to support your physical and emotional health. Speak with your doctor about your activity level and the safety of exercise routines before joining community walking groups.

The takeaway

Maintaining regular movement is often recommended as part of a supportive care plan, but it should always be personalized to your current health status. Discuss any changes in your physical activity or new exercise routines with your oncology team at your next appointment.

Further reading

Learn more about the latest resources and support programs for patients by visiting our Cancer hub.

Source note: This article includes information reported by FiercePharma.

Live Poll

Do you trust pharmaceutical-sponsored lifestyle programs to prioritize patient well-being over corporate interests?